Emcyt and Atrial fibrillation/flutter - a phase IV clinical study of FDA data

Summary:

Atrial fibrillation/flutter is reported as a side effect among people who take Emcyt (estramustine phosphate sodium), especially for people who are male, 60+ old, also take Lasix, and have Prostate cancer.

The phase IV clinical study analyzes which people have Atrial fibrillation/flutter when taking Emcyt. It is created by eHealthMe based on reports of 507 people who have side effects when taking Emcyt from the FDA, and is updated regularly.

What is Emcyt?

Emcyt has active ingredients of estramustine phosphate sodium. eHealthMe is studying from 508 Emcyt users. Check the latest studies of Emcyt.

What is Atrial fibrillation/flutter?

Atrial fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles) is found to be associated with 2,364 drugs and 3,841 conditions by eHealthMe. Check the latest studies of Atrial fibrillation/flutter.

On Jul, 19, 2026

507 people reported to have side effects when taking Emcyt.
Among them, 12 people (2.37%) have Atrial fibrillation/flutter.

Could Emcyt cause Atrial fibrillation/flutter?

Among these 12 people:

What is the gender of people who have Atrial fibrillation/flutter when taking Emcyt? *

female: 9.09 %
male: 90.91 %

What is the age of people who have Atrial fibrillation/flutter when taking Emcyt? *

What are other drugs people take besides Emcyt? *

What are other side effects people have besides Atrial fibrillation/flutter? *

Deformity (disfigurement): 8 people, 66.67%
Cardiac Failure Congestive: 8 people, 66.67%
Gait Disturbance: 8 people, 66.67%
Tooth Fracture: 8 people, 66.67%
Failure To Thrive (inadequate weight gain and physical growth in children): 8 people, 66.67%
Metastases To Bone (cancer spreads to bone): 8 people, 66.67%
Metastases To Lung (cancer spreads to lung): 8 people, 66.67%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 8 people, 66.67%
Emotional Distress: 8 people, 66.67%
Dyskinesia (abnormality or impairment of voluntary movement): 8 people, 66.67%

What are the existing conditions these people have? *

Prostate Cancer: 4 people, 33.33%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 8.33%
Depression: 1 person, 8.33%
Bipolar Disorder (mood disorder): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Emcyt and have Atrial fibrillation/flutter?

- Check whether Atrial fibrillation/flutter is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Emcyt:

Emcyt (508 reports)

Browse all side effects of Emcyt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Atrial fibrillation/flutter:

Atrial fibrillation/flutter (2,364 drugs)

Browse all the conditions that are associated with Atrial fibrillation/flutter:

Atrial fibrillation/flutter (3,841 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on estramustine phosphate sodium (the active ingredients of Emcyt) and Emcyt (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.